5 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31704822 | Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines In Vitro and In Vivo. | 2019 Nov | 1 |
2 | 29908090 | Drug resistance profiles of mutations in the RET kinase domain. | 2018 Sep | 2 |
3 | 30447042 | Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model. | 2018 Dec | 1 |
4 | 28912872 | Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma. | 2017 Oct | 1 |
5 | 27496134 | Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. | 2016 Oct | 1 |